Cheng Su, PH.D.

Biomarin Pharmaceutical

Cheng is currently Executive Director of Data Sciences & Analytics at BioMarin.  Cheng has two decades of industry experiences spanning from drug discovery to clinical development. His areas of expertise include high throughput screening, drug combination, assay development, predictive modeling, biomarker, early clinical trials and statistical monitoring. Cheng has led several cross-functional efforts and developed many standard approaches and automated analysis systems for the evaluation of in vivo experiments, immunogenicity assays, and centralized statistical monitoring.

Cheng received his dual-major B.S. in International Trade and Computer Sciences from Shanghai Jiao Tong University, and Ph.D. in statistics from NCSU.